Volitionrx Ltd
VNRX- Exchange
- NYSE
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000093314
No open-market purchases or sales by Volitionrx Ltd insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $2.61M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Volitionrx Ltd insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Volitionrx Ltd, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Forterre Gael | Chief Commercial Officer | 331,338 | Mar 19, 2026 | 8 |
| Rootsaert Rodney Gerard | Secretary | 273,993 | Mar 19, 2026 | 8 |
| Micallef Jacob Vincent | Chief Scientific Officer | 572,179 | Mar 19, 2026 | 5 |
| Plummer Nicholas | GC - Volition Diagnostics | 407,267 | Mar 19, 2026 | 7 |
| Reynolds Cameron John | President and CEO | 3,115,547 | Feb 27, 2026 | 4 |
| Innes Guy Archibald | Director | 1,252,967 | Feb 27, 2026 | 3 |
| Kway Jasmine | CEO - Singapore Volition | 418,614 | Feb 27, 2026 | 2 |
| Hughes Terig | Chief Financial Officer | 684,970 | Feb 27, 2026 | 2 |
| Nguyen Kim | Director | 305,816 | Feb 27, 2026 | 2 |
| Batchelor Ann-Louise | Group Chief Marketing Officer | 324,072 | Feb 27, 2026 | 4 |
| Rubin Ethel | Director | 252,948 | Feb 27, 2026 | 2 |
| Still Timothy I | Director | 1,625,458 | Jan 23, 2026 | 2 |
| Colman Alan | Director | 257,364 | Jan 23, 2026 | 1 |
| Barnes Phillip | Director | 67,368 | Jan 23, 2026 | 1 |
| Butera Salvatore Thomas | CEO - Volition Veterinary | 375,203 | Jan 23, 2026 | 4 |
| Henshall Mickie | Director | 44,206 | Jan 23, 2026 | 1 |
| Retter Andrew | Chief Medical Officer | 146,568 | Nov 4, 2025 | 1 |
| Gaetan Michel | Chief Operating Officer | 256,746 | Oct 7, 2025 | 2 |
| Futcher Edward | Director | 80,436 | Jan 26, 2024 | 0 |
| Faulkes Martin Charles | Executive Director | 1,740,207 | Jan 26, 2024 | 0 |
| Hever Investments Ltd | 10% Owner | 298,419Indirect | Jan 3, 2024 | 0 |
| Eight Corp Ltd | 10% Owner | 298,419Indirect | Jan 3, 2024 | 0 |
| Brudnick Richard | Director | 27,936 | Jan 13, 2023 | 0 |
| Terrell Jason Bradley MD | Chief Medical Officer | 2,326Indirect | Aug 5, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2021 (view filing) | Nov 16 | 2 days | Butera Salvatore ThomasCEO-Volition Veterinary | PPurchase | +10.0K | $4.02 | +$40.2K | New position10.0K after | |
| Apr 13, 2022 (view filing) | Apr 11 | 2 days | Terrell Jason Bradley MDChief Medical Officer | SSale | −10.0K | $2.75 | −$27.5K | −26.8%27.2K after | |
| May 17, 2022 (view filing) | May 16 | 1 day | Innes Guy ArchibaldDirector | PPurchase | +10.0K | $2.37 | +$23.7K | +0.7%1.55M after | |
| Jun 7, 2022 (view filing) | Jun 6 | 1 day | Terrell Jason Bradley MDChief Medical Officer | SSale | −14.9K | $2.47 | −$36.9K | −54.9%12.3K after | |
| Jun 17, 2022 (view filing) | Jun 16 | 1 day | Butera Salvatore ThomasCEO - Volition Veterinary | PPurchase | +10.0K | $2.05 | +$20.5K | +6.9%155.0K after | |
| Aug 4, 2022 (view filing) | Aug 2 | 2 days | Innes Guy ArchibaldDirector | PPurchase | +12.5K | $2.00 | +$25.0K | +0.8%1.56M after | |
| Aug 4, 2022 (view filing) | Aug 2 | 2 days | Innes Guy ArchibaldDirector | PPurchase | +300.0K | $2.00 | +$600.0K | New position75.0K after | 4 lots |
| Aug 23, 2022 (view filing) | Aug 22 | 1 day | Butera Salvatore ThomasCEO - Volition Veterinary | PPurchase | +5.00K | $1.64 | +$8.20K | +3.2%160.0K after | |
| Aug 24, 2022 (view filing) | Aug 23 | 1 day | Butera Salvatore ThomasCEO - Volition Veterinary | PPurchase | +5.00K | $1.60 | +$8.00K | +3.1%165.0K after | From original |
| Aug 30, 2022 (view filing) | Aug 26 | 4 days | Micallef Jacob VincentChief Scientific Officer | PPurchase | +29.0K | $1.74 | +$50.5K | +24.1%149.2K after | |
| Aug 30, 2022 (view filing) | Aug 30 | Same day | Reynolds Cameron JohnPresident and CEO | PPurchase | +3.50K | $1.61 | +$5.63K | +0.3%1.20M after | |
| Sep 20, 2022 (view filing) | Sep 19 | 1 day | Micallef Jacob VincentChief Scientific Officer | PPurchase | +13.0K | $1.70 | +$22.1K | +59.1%35.0K after | |
| Nov 29, 2022 (view filing) | Nov 28 | 1 day | Butera Salvatore ThomasCEO - Volition Veterinary | PPurchase | +5.00K | $2.21 | +$11.1K | +13.5%42.0K after | |
| Dec 12, 2022 (view filing) | Dec 8 | 4 days | Plummer NicholasGC - Volition Diagnostics | PPurchase | +4.80K | $2.07 | +$9.94K | +10.3%51.5K after | |
| Dec 13, 2022 (view filing) | Dec 12 | 1 day | Butera Salvatore ThomasCEO - Volition Veterinary | PPurchase | +4.35K | $2.09 | +$9.09K | +10.4%46.4K after | |
| Dec 19, 2022 (view filing) | Dec 16 | 3 days | Faulkes Martin CharlesDirector | PPurchase | +55.0K | $2.10 | +$115.5K | +3.5%1.64M after | |
| Dec 20, 2022 (view filing) | Dec 16-19 | 4 days | Micallef Jacob VincentChief Scientific Officer | PPurchase | +32.3K | $2.22 | +$71.9K | +20.7%188.4K after | 2 lots |
| Dec 20, 2022 (view filing) | Dec 19 | 1 day | Butera Salvatore ThomasCEO - Volition Veterinary | PPurchase | +5.00K | $2.27 | +$11.3K | +10.8%51.4K after | |
| Feb 23, 2023 (view filing) | Feb 22 | 1 day | Innes Guy ArchibaldDirector | PPurchase | +234.0K | $1.75 | +$409.5K | New position154.5K after | 4 lots |
| Jun 6, 2023 (view filing) | Jun 2 | 4 days | Butera Salvatore ThomasCEO - Volition Veterinary | PPurchase | +10.0K | $1.59 | +$15.9K | +19.5%61.4K after | |
| Aug 16, 2023 (view filing) | Aug 16 | Same day | Reynolds Cameron JohnPresident and CEO | PPurchase | +10.0K | $1.22 | +$12.2K | +0.7%1.49M after | |
| Aug 17, 2023 (view filing) | Aug 16 | 1 day | Butera Salvatore ThomasCEO - Volition Veterinary | PPurchase | +8.00K | $1.21 | +$9.68K | +13.0%69.3K after | |
| Aug 24, 2023 (view filing) | Aug 24 | Same day | Gaetan MichelChief Operating Officer | PPurchase | +5.00K | $1.23 | +$6.15K | +2.4%213.0K after | |
| Aug 25, 2023 (view filing) | Aug 24 | 1 day | Futcher EdwardDirector | PPurchase | +5.00K | $1.22 | +$6.10K | +8.6%62.9K after | |
| Aug 25, 2023 (view filing) | Aug 24 | 1 day | Kway JasmineCEO - Singapore Volition | PPurchase | +5.00K | $1.20 | +$6.00K | +92.6%10.4K after | |
| Aug 28, 2023 (view filing) | Aug 25 | 3 days | Micallef Jacob VincentChief Scientific Officer | PPurchase | +20.0K | $1.24 | +$24.8K | +9.3%235.1K after | |
| Aug 31, 2023 (view filing) | Aug 29-30 | 2 days | Micallef Jacob VincentChief Scientific Officer | PPurchase | +20.0K | $1.25 | +$25.1K | +57.1%55.0K after | 2 lots |
| Sep 1, 2023 (view filing) | Aug 31 | 1 day | Faulkes Martin CharlesDirector | PPurchase | +9.72K | $1.28 | +$12.4K | +0.6%1.67M after | |
| Sep 6, 2023 (view filing) | Sep 5 | 1 day | Barnes PhillipDirector | PPurchase | +5.00K | $1.30 | +$6.50K | +25.4%24.7K after | |
| Sep 19, 2023 (view filing) | Aug 31 | 19 daysLate | Henshall MickieDirector | PPurchase | +3.71K | $1.25 | +$4.63K | +24.7%18.7K after | |
| Nov 17, 2023 (view filing) | Nov 16 | 1 day | Butera Salvatore ThomasCEO - Volition Veterinary | PPurchase | +10.0K | $0.81 | +$8.10K | +14.4%79.3K after | |
| Nov 24, 2023 (view filing) | Nov 22 | 2 days | Innes Guy ArchibaldDirector | PPurchase | +20.0K | $0.71 | +$14.2K | +3.5%597.2K after | |
| Nov 27, 2023 (view filing) | Nov 24 | 3 days | Innes Guy ArchibaldDirector | PPurchase | +10.0K | $0.76 | +$7.60K | +1.7%607.2K after | |
| Nov 28, 2023 (view filing) | Nov 27 | 1 day | Futcher EdwardDirector | PPurchase | +9.00K | $0.80 | +$7.20K | +14.3%71.9K after | |
| Nov 28, 2023 (view filing) | Nov 27 | 1 day | Innes Guy ArchibaldDirector | PPurchase | +20.0K | $0.77 | +$15.4K | +3.3%627.2K after | |
| Dec 11, 2023 (view filing) | Dec 8 | 3 days | Reynolds Cameron JohnPresident and CEO | PPurchase | +10.0K | $0.67 | +$6.70K | +0.6%1.70M after | |
| Dec 14, 2023 (view filing) | Dec 13 | 1 day | Rootsaert Rodney GerardSecretary | PPurchase | +10.0K | $0.60 | +$6.00K | +14.6%78.7K after | |
| Dec 18, 2023 (view filing) | Dec 15 | 3 days | Butera Salvatore ThomasCEO - Volition Veterinary | PPurchase | +10.0K | $0.77 | +$7.70K | +12.6%89.3K after | |
| Dec 19, 2023 (view filing) | Dec 18 | 1 day | Butera Salvatore ThomasCEO - Volition Veterinary | PPurchase | +10.0K | $0.83 | +$8.30K | +11.2%99.3K after | |
| Dec 20, 2023 (view filing)10:31 AM ET | Dec 15 | 5 daysLate | Hever Investments Ltd and 1 other10% Owner | SSale | −20.0K | $0.75 | −$15.0K | −5.9%318.4K after | |
| Jan 3, 2024 (view filing)10:41 AM ET | Jan 2 | 1 day | Hever Investments Ltd and 1 other10% Owner | SSaleVOLITIONRX LTD | −20.0K | $0.90 | −$18.0K | −6.3%298.4K after | |
| Aug 21, 2024 (view filing) | Aug 20 | 1 day | Innes Guy ArchibaldDirector | PPurchase | +150.0K | $0.67 | +$100.5K | +58.4%406.7K after | |
| Dec 10, 2024 (view filing) | Dec 9 | 1 day | Reynolds Cameron JohnPresident and CEO | PPurchase | +139.8K | $0.57 | +$79.7K | +7.1%2.12M after | |
| Dec 10, 2024 (view filing) | Dec 9 | 1 day | Micallef Jacob VincentChief Scientific Officer | PPurchase | +43.7K | $0.57 | +$24.9K | +12.5%394.4K after | |
| Dec 10, 2024 (view filing) | Dec 9 | 1 day | Still Timothy IDirector | PPurchase | +87.4K | $0.57 | +$49.8K | +6.2%1.49M after | |
| Dec 10, 2024 (view filing) | Dec 9 | 1 day | Innes Guy ArchibaldDirector | PPurchase | +174.8K | $0.57 | +$99.6K | +39.5%617.1K after | |
| Mar 27, 2025 (view filing) | Mar 26 | 1 day | Innes Guy ArchibaldDirector | PPurchase | +181.8K | $0.55 | +$100.0K | +26.5%868.7K after | |
| Mar 27, 2025 (view filing) | Mar 26 | 1 day | Reynolds Cameron JohnPresident and CEO | PPurchase | +181.8K | $0.55 | +$100.0K | +8.6%2.30M after | |
| May 19, 2025 (view filing)12:43 PM ET | May 19 | Same day | Reynolds Cameron JohnPresident and CEO | PPurchase | +20.0K | $0.4365 | +$8.73K | +0.9%2.32M after | |
| May 19, 2025 (view filing)1:23 PM ET | May 19 | Same day | Micallef Jacob VincentChief Scientific Officer | PPurchase | +50.0K | $0.43 | +$21.5K | +13.3%426.0K after |